Robert Califf

Entity
Individual
Business address
Portola Pharmaceuticals, Inc., 270 East Grand Avenue, 94080 South San Francisco, CA
Signature Ownership
By: Robert Wong For: Robert Califf
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Robert Califf has filed 20 SEC EDGAR filings since 5/21/2013

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT Jan 4, 2022 Jan 3, 2022 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Oct 4, 2021 Oct 1, 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Jul 8, 2021 Jul 7, 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Jul 2, 2021 Jul 1, 2021 000-50633
3 Open Document Open Filing FORM 3 SUBMISSION May 27, 2021 May 27, 2021 001-40445
4 Open Document Open Filing PRIMARY DOCUMENT May 13, 2021 May 12, 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Apr 5, 2021 Apr 1, 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Jan 5, 2021 Jan 4, 2021 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT May 14, 2020 May 13, 2020 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Feb 14, 2020 Feb 12, 2020 000-50633
4/A Open Document Open Filing PRIMARY DOCUMENT Jan 29, 2020 Jan 2, 2020 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Jan 6, 2020 Jan 2, 2020 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT May 17, 2019 May 15, 2019 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Jan 4, 2019 Jan 2, 2019 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT May 17, 2018 May 16, 2018 000-50633
4 Open Document Open Filing PRIMARY DOCUMENT Feb 12, 2018 Feb 8, 2018 000-50633
3 Open Document Open Filing PRIMARY DOCUMENT Feb 12, 2018 Feb 8, 2018 000-50633
4 Open Document Open Filing FORM 4 SUBMISSION Jul 1, 2014 Jun 27, 2014 001-35935